Follicular Lymphoma Clinical Trials

A listing of 58 Follicular Lymphoma clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Conditions

Follicular Lymphoma

1 - 12 of 58

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

There are currently 58 active clinical trials seeking participants for Follicular Lymphoma research studies. The states with the highest number of trials for Follicular Lymphoma participants are Texas, California, New York and Florida.

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Chronic Cough Study

Recruiting

Are you tired of living with chronic cough? The ASPIRE Study is now looking to enroll people from all backgrounds to help research potential new treatment options for chronic cough. You are under no obligation to take part and health insurance is not required. Find out more today! We’d love to hear from you.

Conditions:

Chronic Cough

Refractory or Unexplained Chronic Cough

Cough

Asthma

Allergic Asthma

Learn More

Featured Trial

Studying an Investigational Virus Vaccine

Recruiting

The main objectives of this study are to assess the safety and effectiveness of an investigational vaccine aimed at preventing norovirus, commonly known as the stomach flu. Participants will be randomly assigned to receive either the investigational vaccine or a placebo. Should you express interest, you will be contacted directly by the research site, which will provide further details and answer any questions you may have about study requirements, risks/benefits, and any compensation.

Conditions:

Healthy

Interested in vaccine studies

All Conditions

Preventative Trials

Learn More

Featured Trial

Major Depressive Disorder Clinical Study

Recruiting

Is depression weighing you down? Local major depressive disorder clinical studies are now enrolling participants in the area. Participating in research studies helps contribute to the advancement of future medicine and treatment options. There is no obligation to take part and health insurance is not required.

Conditions:

Major Depressive Disorder

Major Depression

Major Depressive Episode

Major Depressive Disorder (MDD)

Major Depressive Disorders

Learn More

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

NCT05006716

Recruiting

Study consists of two main parts to explore BGB-16673 recommended dosing, a Phase 1 monotherapy dose finding comprised of monotherapy dose escalation and monotherapy safety expansion of selected doses, and a Phase 2 (expansion cohorts)

Gender:

ALL

Ages:

18 years and above

Trial Updated:

03/21/2025

Locations: University of Alabama At Birmingham Hospital, Birmingham, Alabama +118 locations

University of Alabama At Birmingham Hospital, Birmingham, Alabama

Western Regional Medical Center, Llc, Goodyear, Arizona

Mayo Clinic Phoenix, Phoenix, Arizona

Honor Health Research Institute, Scottsdale, Arizona

University of Arizona Cancer Center, Tucson, Arizona

University of California San Diego (Ucsd) Moores Cancer Center, La Jolla, California

UCLA Santa Monica Cancer Care, Santa Monica, California

Stanford Medicine, Stanford, California

Uchealth North, Fort Collins, Colorado

Mayo Clinic Jacksonville, Jacksonville, Florida

Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida

Tampa General Hospital Cancer Institute, Tampa, Florida

Augusta University, Augusta, Georgia

Southeastern Regional Medical Center, Newnan, Georgia

Midwestern Regional Medical Center, Zion, Illinois

University of Iowa Hospitals and Clinics, Iowa City, Iowa

Norton Cancer Institute Pavilion, Louisville, Kentucky

Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana

American Oncology Partners of Maryland Pa, Bethesda, Maryland

Dana Farber Cancer Institute, Boston, Massachusetts

Karmanos Cancer Institute, Detroit, Michigan

Mayo Clinic Rochester, Rochester, Minnesota

Nebraska Cancer Specialists, Grand Island, Nebraska

Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada

Summit Medical Group, Florham Park, New Jersey

Roswell Park Comprehensive Cancer Center, Buffalo, New York

Weill Cornell Medical College Newyork Presbyterian Hospital, New York, New York

Columbia University Medical Center, New York, New York

Memorial Sloan Kettering Cancer Center Mskcc, New York, New York

Tennesse Oncology Chattanooga, Chattanooga, Tennessee

Tennessee Oncology, Pllc Nashville, Nashville, Tennessee

Md Anderson Cancer Center, Houston, Texas

Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia

Fred Hutchinson Cancer Research Center, Seattle, Washington

Concord Repatriation General Hospital, Concord, New South Wales

Calvary Mater Newcastle, Waratah, New South Wales

Princess Alexandra Hospital, Brisbane, Queensland

St Vincents Hospital Melbourne, Fitzroy, Victoria

Peninsula Private Hospital, Frankston, Victoria

Austin Health, Heidelberg, Victoria

Peter Maccallum Cancer Centre, Melbourne, Victoria

The Alfred Hospital, Melbourne, Victoria

Linear Clinical Research, Nedlands, Western Australia

Perth Blood Institute, West Perth, Western Australia

Hospital Sirio Libanes Brasilia, Brasilia, Not set

Instituto de Pesquisa Em Saude Da Universidade de Caxias Do Sul, Caxias do Sul, Not set

Hospital Erasto Gaertner, Curitiba, Not set

Hospital Ernesto Dornelles, Porto Alegre, Not set

Centro Gaucho Integrado de Oncologia Hospital Mae de Deus, Porto Alegre, Not set

Real E Benemerita Associacao Portuguesa de Sao Paulo, Sao Paulo, Not set

Instituto Dor de Pesquisa E Ensino Sao Paulo, Sao Paulo, Not set

Hospital Nove de Julho Dasa, Sao Paulo, Not set

Hospital Alemao Oswaldo Cruz, Sao Paulo, Not set

Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, Sao Paulo, Not set

Hospital Santa Rita de Cassia Afecc, Vitoria, Not set

Cross Cancer Institute, Edmonton, Alberta

British Columbia Cancer Agency the Vancouver Centre, Vancouver, British Columbia

Princess Margaret Cancer Centre, Toronto, Ontario

Arthur Je Child Comprehensive Cancer Centre, Calgary, Not set

Chu de Quebec Universite Laval, Hopital de Lenfant Jesus, Centre Integre de Cancerologie (Cic), Quebec, Not set

Centre de Lutte Contre Le Cancer Institut Bergonie, Bordeaux, Not set

Hopital Estaing, Clermont Ferrand, Not set

Chu Henri Mondor, Creteil, Not set

Hopital Claude Huriez Chu Lille, Lille, Not set

Centre Leon Berard, Lyon Cedex, Not set

Institut Paoli Calmettes, Marseille, Not set

Chu Montpellier Hopital Saint Eloi, Montpellier Cedex, Not set

Hopital de La Pitie Salpetriere, Paris, Not set

Centre Henri Becquerel, Rouen Cedex, Not set

Arensia Exploratory Medicine Llc, Tbilisi, Not set

Universitatsklinikum Carl Gustav Carus An Der Technischen Universitat Dresden, Dresden, Not set

Uniklinik Koln (Aor), Koln, Not set

Universitares Krebszentrum Leipzig, Leipzig, Not set

Universitaetsklinikum Schleswig Holstein Campus Luebeck, Luebeck, Not set

Klinikum Johannes Gutenberg Universitaet Mainz, Mainz, Not set

Klinikum Grosshadern Ludwig Maximilians Universitat Munchen, Munich, Not set

Universitaetsklinikum Ulm, Innere Medizin Iii, Ulm, Not set

Policlinico Sorsola Malpighi, Aou Di Bologna, Bologna, Not set

Ospedale San Raffaele, Milano, Not set

Istituto Europeo Di Oncologia, Milano, Not set

Niguarda Cancer Center Division of Hematology, Milano, Not set

Fondazione Policlinico Universitario Agostino Gemelli, Roma, Not set

Centroricerche Cliniche Di Verona Srl, Verona, Not set

Aichi Cancer Center Hospital Clinical Oncology, Nagoya, Aichi

Chiba Cancer Center, Chibashi, Chiba

National Cancer Center Hospital East, Kashiwa, Chiba

Cancer Institute Hospital of Jfcr, Kotoku, Tokyo

Yokohama Municipal Citizens Hospital, Yokohamashi, Not set

Inje University Busan Paik Hospital, Busan, Busan Gwang'yeogsi

Pusan National University Hospital, Busan, Busan Gwang'yeogsi

Seoul National University Hospital, Seoul, Seoul Teugbyeolsi

Severance Hospital Yonsei University Health System, Seoul, Seoul Teugbyeolsi

Asan Medical Center, Seoul, Seoul Teugbyeolsi

Samsung Medical Center, Seoul, Seoul Teugbyeolsi

The Catholic University of Korea, Seoul St Marys Hospital, Seoul, Seoul Teugbyeolsi

The Institute of Oncology, Arensia Exploratory Medicine, Chisinau, Not set

Hospital de La Santa Creu I Sant Pau, Barcelona, Not set

Hospital Universitario Vall Dhebron, Barcelona, Not set

Hospital General Universitario Gregorio Maranon, Madrid, Not set

Md Anderson Cancer Center Madrid Spain, Madrid, Not set

Hospital Universitario Fundacion Jimenez Diaz, Madrid, Not set

Hospital Universitario La Paz, Madrid, Not set

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Not set

Hospital Clinico Universitario de Valencia, Valencia, Not set

Sahlgrenska University Hospital Hematology, Goteborg, Not set

Karolinska Universitetssjukhuset Solna, Stockholm, Not set

Uppsala Akademiska Sjukhus, Uppsala, Not set

Dr Abdurrahman Yurtaslan Research and Training Hospital, Ankara, Not set

Ankara University, Ankara, Not set

Dokuz Eylul University, Izmir, Not set

Erciyes University, Kayseri, Not set

Sakarya Training and Research Hospital, Sakarya, Not set

Ondokuz Mayis University, Samsun, Not set

Edinburgh Cancer Centre, Edinburgh, Not set

Churchill Hospital Oxford University Hospital Nhs Trust, Headington, Not set

St Jamess University Hospital, Leeds, Not set

Freeman Hospital, NewCastle Upon Tyne, Not set

Nottingham University Hospitals Nhs Trust, Nottingham, Not set

Derriford Hospital, Plymouth, Not set

Conditions: B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-hodgkin Lymphoma, Waldenström Macroglobulinemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Diffuse Large B Cell Lymphoma

Learn More ›

Clonal Evolution in Follicular Lymphoma

NCT03190928

Recruiting

Background: Follicular lymphoma is a type of cancer of the lymph nodes. Lab studies are important for cancer research. They help scientists better understand differences in the cancer biology of different patients. Researchers want to collect serial samples over time from people with follicular lymphoma to help them design future treatments. Objective: To collect a variety of samples from people with follicular lymphoma to study how these diseases progress and respond to treatment. Eligibili... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

03/21/2025

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Follicular Lymphoma

Learn More ›

Mosunetuzumab with Lenalidomide Augmentation As First-line Therapy for Follicular and Marginal Zone Lymphoma

NCT04792502

Recruiting

BrUOG-401 is a prospective, single-arm, phase 2 trial of first-line therapy in adult patients with previously untreated FL or MZL. All patients will be assigned the same initial treatment plan, modified by interim response assessment (IRA) after Cycle 4. All patients will start treatment with four 21-day cycles (C1-4) of mosunetuzumab alone (using step-up dosing during C1), followed by IRA. Patients who achieve CR at IRA will continue with additional 4 cycles (C5-8) of mosunetuzumab. Patients wh... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

03/19/2025

Locations: Yale Cancer Center, New Haven, Connecticut +2 locations

Conditions: Follicular Lymphoma, Marginal Zone Lymphoma, B-cell Lymphoma

Learn More ›

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

NCT06022029

Recruiting

A phase 1, multicenter, open label, non-randomized dose escalation and dose expansion study to examine the maximum tolerated dose, (MTD), minimum effective dose (MED) and/or recommended dose for expansion (RDE) of intratumoral ONM-501 as monotherapy and in combination with a PD-1 checkpoint inhibitor in patients with advanced solid tumors and lymphomas.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

03/18/2025

Locations: California Research Institute, Los Angeles, California +14 locations

Conditions: Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Lymphoma, Non-Hodgkin, Mantle Cell Lymphoma, Bladder Cancer, Uveal Melanoma, Recurrent, Cervix Cancer, Carcinoma in Situ, Head and Neck Squamous Cell Carcinoma, Skin Cancer, Metastatic Cancer, Tumor, Solid, Tumor Recurrence

Learn More ›

Study of the Monoclonal Antibody IMT-009 in Patients with Advanced Solid Tumors or Lymphomas

NCT05565417

Recruiting

This is a Phase 1/2a open-label, multicenter, dose escalation and dose expansion trial in which IMT-009 will be administered by the intravenous (IV) route to participants with solid tumors or lymphomas. The main goals of this study are to: * Find the recommended dose of IMT-009 that can be safely given to participants * Learn more about the side effects of IMT-009 * Learn more about pharmacokinetics of IMT-009 * Learn more about the effectiveness of IMT-009 * Learn more about different pharmac... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

03/18/2025

Locations: Site 9618, Tucson, Arizona +9 locations

Conditions: Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer, Cutaneous Squamous Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma, Small Bowel Cancer, Esophageal Cancer, Colorectal Cancer, Diffuse Large B Cell Lymphoma, Hodgkin Lymphoma, Burkitt Lymphoma, Follicular Lymphoma

Learn More ›

Vaccine Responses in Patient with Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

NCT06784167

Recruiting

This study evaluates immune responses after CAR-T therapy to find out if CAR-T therapy reduces the effectiveness of the vaccines (vaccine immunity) against diseases such as measles, mumps and rubella, among others in patients with multiple myeloma and non-Hodgkin lymphoma.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

03/17/2025

Locations: OHSU Knight Cancer Institute, Portland, Oregon

Conditions: Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Primary Mediastinal Large B-Cell Lymphoma, Small Lymphocytic Lymphoma

Learn More ›

Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma

NCT06108232

Recruiting

To learn if obinutuzumab in combination with CC-99282 can help to control previously untreated, high tumor burden FL

Gender:

ALL

Ages:

18 years and above

Trial Updated:

03/11/2025

Locations: M D Anderson Cancer Center, Houston, Texas

Conditions: Follicular Lymphoma, Tumor

Learn More ›

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma

NCT04246086

Recruiting

This study will evaluate the safety, efficacy, pharmacokinetics, and immunogenicity of mosunetuzumab (Mosun) + lenalidomide (Len) (Mosun + Len) in participants with follicular lymphoma (FL). This study will also compare the pharmacokinetics, pharmacodynamics, safety, efficacy, and immunogenicity of IV mosunetuzumab + len vs subcutaneous (SC) mosunetuzumab + len.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

03/06/2025

Locations: City of Hope National Medical Center, Duarte, California +22 locations

City of Hope National Medical Center, Duarte, California

Swedish Medical Center, Seattle, Washington

the First Hospital of Jilin University, Changchun, Not set

Hunan Cancer Hospital, Changsha City, Not set

West China Hospital, Sichuan University, Chengdu, Not set

Fudan University Shanghai Cancer Center, Shanghai City, Not set

Tianjin Medical University Cancer Institute & Hospital, Tianjing, Not set

The First Affiliated Hospital of Xiamen University, Xiamen, Not set

CHRU de Lille - Hopital Claude Huriez, Lille, Not set

CHU Montpellier, Montpellier, Not set

Hôpital Saint-Louis, Paris, Not set

Centre Hospitalier Lyon Sud, Pierre Benite, Not set

CHU Rennes - Hopital Pontchaillou, Rennes cedex 09, Not set

Institut Claudius Regaud, Toulouse, Not set

Hospital Universitario Vall d Hebron, Barcelona, Not set

Hospital Universitario Fundacion Jimenez Diaz., Madrid, Not set

Hospital Universitario Virgen de la Victoria, Malaga, Not set

Complejo Asistencial Universitario de Salamanca, Salamanca, Not set

University College London Hospitals NHS Foundation Trust - University College Hospital, London, Not set

The Christie NHS Foundation Trust, Manchester, Not set

Freeman Hospital, Newcastle upon Tyne, Not set

Nottingham University Hospitals NHS Trust - City Hospital, Nottingham, Not set

Oxford University Hospitals NHS Foundation Trust, Oxford, Not set

Conditions: Follicular Lymphoma

Learn More ›

Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

NCT04223765

Recruiting

This study will combine both T cells and antibodies in order to create a more effective treatment. The treatment tested in this study uses modified T-cells called Autologous T Lymphocyte Chimeric Antigen Receptor (ATLCAR) cells targeted against the kappa light chain antibody on cancer cells. For this study, the anti-kappa light chain antibody has been changed so instead of floating free in the blood, a part of it is now joined to the T cells. Only the part of the antibody that sticks to the lymphoma cells is attached to the T cells. When an antibody is joined to a T cell in this way, it is called a chimeric receptor. The kappa light chain chimeric (combination) receptor-activated T cells are called ATLCAR.κ.28 cells. These cells may be able to destroy lymphoma cancer cells. They do not, however, last very long in the body so their chances of fighting the cancer are unknown. Previous studies have shown that a new gene can be put into T cells to increase their ability to recognize and kill cancer cells. A gene is a unit of DNA. Genes make up the chemical structure carrying your genetic information that may determine human characteristics (i.e., eye color, height and sex). The new gene that is put in the T cells in this study makes an antibody called an anti-kappa light chain. This anti-kappa light chain antibody usually floats around in the blood. The antibody can detect and stick to cancer cells called lymphoma cells because they have a substance on the outside of the cells called kappa light chains. The purpose of this study is to determine whether receiving the ATLCAR.κ.28 cells is safe and tolerable and learn more about the side effects and how effective these cells are in fighting lymphoma. Initially, the study doctors will test different doses of the ATLCAR.κ.28, to see which dose is safer for use in lymphoma patients. Once a safe dose is identified, the study team will administer this dose to more patients, to learn about how these cells affect lymphoma cancer cells and identify other side effects they might have on the body. This is the first time ATLCAR.κ.28 cells are given to patients with lymphoma. The Food and Drug Administration (FDA), has not approved giving ATLCAR.κ.28 as treatment for lymphoma. This is the first step in determining whether giving ATLCAR.κ.28 to others with lymphoma in the future will help them. Read Less

Gender:

ALL

Ages:

18 years and above

Trial Updated:

02/28/2025

Locations: Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, North Carolina

Conditions: Mantle Cell Lymphoma, Follicular Lymphoma, Splenic Marginal Zone Lymphoma, Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Nodal Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma

Learn More ›

A Long-term Extension Study of PCI-32765 (Ibrutinib)

NCT01804686

Recruiting

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who are currently enrolled in ibrutinib studies that have been completed according to the parent protocol, are actively receiving treatment with ibrutinib, and who continue to benefit from ibrutinib treatment.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

02/27/2025

Locations: City of Hope Cancer Center, Duarte, California +173 locations

City of Hope Cancer Center, Duarte, California

University of California San Diego Medical Center, La Jolla, California

University of California Los Angeles, Los Angeles, California

St. Joseph Hospital Center for Cancer Prevention and Treatment, Orange, California

Stanford University Medical Center, Stanford, California

Stanford University, Stanford, California

Norwalk Medical Group, Norwalk, Connecticut

Northwest Georgia Oncology Centers PC, Marietta, Georgia

Northwestern University Hospital, Chicago, Illinois

Indiana University, Goshen, Indiana

Kansas University Medical Center, Westwood, Kansas

Louisville Oncology Suburban - Norton Cancer Institute, Louisville, Kentucky

Dana Farber Cancer Center, Boston, Massachusetts

University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Battle Creek Health Systm, Battle Creek, Michigan

Karmanos Cancer Institute - Wayne State University, Detroit, Michigan

Washington University, Saint Louis, Missouri

Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire

Hackensack University Medical Center, Hackensack, New Jersey

Weill Medical College of Cornell University, New York, New York

Memorial Sloan-Kettering Cancer Center, New York, New York

Southeastern Medical Oncology Center, Goldsboro, North Carolina

The Ohio State University- James Cancer Hospital, Columbus, Ohio

Willamette Valley Cancer Center, Eugene, Oregon

Kaiser Permanente, Portland, Oregon

University of Pennsylvania Medical Center, Philadelphia, Pennsylvania

Avera Medical Group, Sioux Falls, South Dakota

MD Anderson Cancer Center - University of Texas, Houston, Texas

University of Virginia, Charlottesville, Virginia

University of Washington, Seattle, Washington

West Virginia University, Morgantown, West Virginia

University of Wisconsin Carbone Cancer Center - Wisconsin Institute for Medical Research, Madison, Wisconsin

CEMIC Saavedra, Ciudad Autonoma Buenos Aires, Not set

Fundaleu, Ciudad de Buenos Aires, Not set

Royal Adelaide Hospital, Adelaide, Not set

John Fawkner Cancer Trial Centre, Coburg, Not set

Concord Hospital, Concord, Not set

Austin Health, Heidelberg, Not set

Peter MacCallum Cancer Institute, Melbourne, Not set

Royal Perth Hospital, Perth, Not set

Alfred Hospital, Prahran, Not set

Adventist Health Care Limited trading as San Clinical Trials Unit, Wahroonga, Not set

UZA, Antwerp, Not set

A.Z. Sint Jan, Brugge, Not set

UCL - Saint Luc, Brussels, Not set

UZ Gent - departement oncologie, Gent, Not set

UZ Leuven Gasthuisberg, Leuven, Not set

UCL Mont-Godinne, Yvoir, Not set

Ministerio da Saude Instituto Nacional do Cancer, Rio De Janeiro, Not set

Santa Casa da Misericórdia da Bahia - Hospital Santa Isabel, Salvador, Not set

Instituto de Ensino e Pesquisa São Lucas, Sao Paulo, Not set

Jewish General Hospital, Montreal, Quebec

Peking University People s Hospital, Beijing, Not set

Peking University Third Hospital, Beijing, Not set

Peking University First Hospital, Beijing, Not set

West China Hospital Sichuan University, Chengdu, Not set

Fujian Medical University, Fuzhou, Not set

Sun Yat-sen University Cancer Hospital, Guangzhou, Not set

Zhejiang University First Hospital, Hangzhou, Not set

Ruijin Hospital, Shanghai, Not set

Tangdu hospital the Fourth Military Medical, Shanxi, Not set

The First Affliated Hospital of Soochow University, Suzhou, Not set

The Institute of Hematological disease, Tianjin, Not set

Wuhan Union Hospital, Wuhan, Not set

Fundacion Santa Fe, Bogota, Not set

Fundacion Oftalmologica de Santander - FOSCAL, Floridablanca, Not set

Fakultni nemocnice Brno, Interni hematologicka a onkologicka klinika, Brno, Not set

Fakultni nemocnice Kralovske Vinohrady - Interni hematologicka klinika, Praha 10, Not set

Vseobecna fakultni nemocnice v Praze - I. interni klinika - klinika hematologie, Praha 2, Not set

Hopital Henri Mondor, Creteil, Not set

Hôpital E. Muller, Mulhouse, Not set

Hopital Necker Enfants Malades, Paris cedex 15, Not set

HOPITAL SAINT LOUIS - Hematology / Oncology, Paris, Not set

Hopital Haut Leveque Service Maladie Du Sang, Pessac, Not set

CH LYON SUD - Hematology, Pierre Benite, Not set

CHU de Tours, Tours, Not set

Vivantes Klinikum Spandau-Klinik f. Innere Medizin Hämatologie/Onkologie/Gastroenterologie - Germany, Berlin, Not set

Universitätsklinikum Carl Gustav Carus; Med. Klinik und Poliklinik I - Hämatologische Ambulanz, Haus, Dresden, Not set

Universitätsklinikum Essen; Klinik f. Hämatologie- Germany, Essen, Not set

Justus-Liebig-Universitaet - Medizinische Klinik IV, Haematologie, Gießen, Not set

Universitätsklinikum Heidelberg Med. Klinik IV, Heidelberg, Not set

Universitätsklinikum des Saarlandes, Homburg/Saar, Not set

Gemeinschaftspraxis Dres. Uhle/Müller/Kröning/Jentsch-Ullrich - Germany, Magdeburg, Not set

OnkoNet Marburg GmbH, Marburg, Not set

Universitätsklinikum für Innere Med. III_Hämatologie, Onkologie...- Germany, Ulm, Not set

Laiko General Hospital - 1st department of Internal Medicine, Athens, Not set

G Papanikolaou Hospital of Thessaloniki, Thessalonikis, Not set

Semmelweis Egyetem, I. Belgyogyaszati Klinika, Budapest N/a, Not set

Szegedi Tudomanyegyetem II. Belgyogyaszati Klinika, Szeged, Not set

St James's Hospital, Dublin, Not set

Haemek Medical Center, Afula, Not set

Hillel Yaffe Medical Center - Oncology, Hadera, Not set

Rambam Health Care Campus, Haifa, Not set

Rabin Medical Center Beilinson Campus, Petah Tikva, Not set

Sheba Medical Center, Ramat-Gan, Not set

Tel Aviv Sourasky Medical Center, Tel Aviv, Not set

ASST Grande Ospedale Metropolitano Niguarda, Milano, Not set

DIPARTIMENTO DI BIOTECNOLOGIE CELLULARI ED EMATOLOGIA - UNIVERSITà ''LA SAPIENZA'', Roma, Not set

A.O.Citta della Salute e della Scienza di Torino, Torino, Not set

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo ku, Not set

Hiroshima University Hospital, Hiroshima shi, Not set

Hokkaido University Hospital, Sapporo-shi, Not set

National Cancer Center, Goyang-Si, Not set

The Catholic University of Korea Seoul St Mary s Hospital, Seoul, Not set

Oaxaca Site Management Organization S.C., Oaxaca, Not set

VU medisch centrum - Afd.Interne - INT, Amsterdam, Not set

Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im Ks B Markiewicza, Brzozow, Not set

Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespol Szpitali Miejskich, Chorzow, Not set

Uniwersyteckie Centrum Kliniczne, Gdansk, Not set

Pratia MCM Krakow, Krakow, Not set

Oddzial Hematologii, Opole, Not set

Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka, Slupsk, Not set

Katedra I Klinika Hematologii Nowotworow Krwi I Transplantacji Szpiku, Wroclaw, Not set

Instituto Portugues de Oncologia, Lisboa, Not set

Hospital De Santa Maria, Lisbon, Not set

Instituto Portugues de Oncologia, Porto, Not set

Auxilio Mutuo Cancer Center, San Juan, Not set

Arkhangelsk Regional Clinical Hospital, Arkhangelsk, Not set

Chelyabinsk Regiona Onc. Center, Chelyabinsk, Not set

Emergency Hospital of Dzerzhinsk, Dzerzhinsk, Not set

Cancer Research Center, Moscow N/a, Not set

S.P. Botkin Moscow City Clinical Hospital, Moscow, Not set

Regional Clinical Hospital n.a.Semashko, Nizhni Novgorod, Not set

Medical Scientific Radiology - Center, Obninsk, Not set

Perm Medical Sanitary Unit#1, Perm, Not set

Republican Hospital named by V.A.Baranova, Petrozavodsk, Not set

Rostov Research Institute of Oncology, Rostov-Na-Donu, Not set

Ryazan Regional Clinical Hospital, Ryazan, Not set

Leningrad region clinical hospital, Saint, Not set

Samara Region Clinical Hospital, Samara, Not set

Federal Center of Heart, Blood and Endocrinology, Sankt-Peterburg, Not set

Oncological dispensary #2, Sochi, Not set

City Clinical Oncology Dispensary, St. Petersburg, Not set

Clinical Research Institute of Hematology and Transfusiology, St.-Petersburg, Not set

Oncology Dispensary of Komi Republic, Syktyvkar, Not set

Hospital Vall d'Hebron, Barcelona N/a, Not set

Inst. Cat. Doncologia-H Duran I Reynals, L'hospitalet De Llobregat, Not set

Hosp. Univ. de La Princesa, Madrid, Not set

Hosp. Gral. Univ. Gregorio Maranon, Madrid, Not set

Hosp. Univ. Infanta Leonor, Madrid, Not set

Fundacion Jimenez Diaz, Madrid, Not set

Clinica Universitaria de Navarra, Pamplona N/a, Not set

Hospital Clinico Universitario Salamanca, Salamanca, Not set

Sahlgrenska University hospital, Hematology Dept, Göteborg, Not set

Skanes universitetssjukhus, Lund, Not set

Karolinska Universitetssjukhuset Solna, Centrum för Hematologi, Stockholm, Stockholm, Not set

Changhua Cristian Hospital, Changhua County, Not set

Ankara University, Ankara, Not set

American Hospital, Istanbul, Not set

Istanbul University, Istanbul, Not set

Dokuz Eylul Universitesi Tip Fakultesi, Izmir, Not set

Erciyes University, Kayseri, Not set

Communal Nonprofit Enterprise 'Cherkasy Regional Oncology Dispensary Of Cherkasy Regional Council', Cherkasy, Not set

Dnepropetrovsk City Clinical Hospital #4, Regional Hematology Center, Dnepropetrovsk, Not set

SI Grigoriev Institute for Medical Radiology National Academy of Medical Science of Ukraine, Kharkiv, Not set

Khmelnitskiy Regional Hospital, Hematology Department, Khmelnitskiy, Not set

State Institution Scientific Center for Radiation Medicine Academy of Medical Sciences of Ukraine, Kiev, Not set

Institute of Blood Pathology and Transfusion Medicine of AMS of Ukraine, Lviv, Not set

Vinnytsya Regional Clinical Hospital named after M.I.Pirogov, Vinnitsa, Not set

University Hospitals Birmingham NHS Trust,, Birmingham, Not set

Royal Bournemouth Hospital, Bournemouth, Not set

Colchester Hospital University NHS, Colchester, Not set

Beatson West Of Scotland Cancer Centre, Glasgow, Not set

St James's Institute of Oncology, Leeds, Not set

Leicester Royal Infirmary - Haematology, Leicester, Not set

St Bartholomew's Hospital - Dept of Haematology, London, Not set

University College London Hospitals NHSFT, London, Not set

Kings College Hospital, London, Not set

Christie Hospital, Manchester, Not set

Nottingham University Hospitals NHS Trust, Nottingham, Not set

Derriford Hospital, Plymouth, Not set

Royal Hallamshire Hospital, Sheffield, Not set

Southampton General Hospital, Southampton, Not set

Royal Marsden Hospital (Sutton), Sutton, Not set

Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma, Diffuse Large B-cell Lymphoma, Waldenstrom Macroglobulinemia, Chronic Graft Versus Host Disease

Learn More ›

A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

NCT04224493

Recruiting

The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to esta... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

02/27/2025

Locations: Southern Cancer Center, Mobile, Alabama +191 locations

Southern Cancer Center, Mobile, Alabama

Arizona Oncology Associates - Tuscon-Rusadill Road, Tucson, Arizona

TOI - Clinical Research, Cerritos, California

UCSF Fresno, Clovis, California

UC San Diego Health Sciences, La Jolla, California

UCLA Clinical Research Unit Hematology/Oncology, Santa Monica, California

Rocky Mountain Cancer Centers (RMCC) - Boulder, Boulder, Colorado

St. Mary's Hospital and Regional Medical Center - St. Mary's, Grand Junction, Colorado

SCL Health Lutheran Medical Center, Greeley, Colorado

Cancer Specialists of North Florida, Fleming Island, Florida

Florida Cancer Specialists & Research Institute (FCS) - Fort Myers Cancer Center, Fort Myers, Florida

Mayo Clinic - Cancer Clinical Research Office, Jacksonville, Florida

Mayo Clinic, Jacksonville, Florida

Miami Cancer Institute, Miami, Florida

Florida Cancer Affiliates/Ocala Oncology - Clinic, Ocala, Florida

BRCR Medical Center, INC, Plantation, Florida

Florida Cancer Specialists, Saint Petersburg, Florida

Florida Cancer Specialists - Panhandle, Tallahassee, Florida

H Lee Moffitt Cancer Center and Research Institute I, Tampa, Florida

Florida Cancer Specialists & Research Institute (FCS) - Atlantis, West Palm Beach, Florida

Kaiser Permanente Hawaii Moanalua Medical Center, Honolulu, Hawaii

University of Chicago, Chicago, Illinois

Illinois Cancer Specialists, Niles, Illinois

June E. Nylen Cancer Center, Sioux City, Iowa

The University of Kansas Cancer Center, Overland Park, Kansas

University of Maryland, Baltimore, Maryland

The office of Frederick P. Smith, MD, P.C., Chevy Chase, Maryland

Mass General Cancer Center at Newton-Wellesley, Newton, Massachusetts

University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

St. Joseph Mercy Hospital, Ypsilanti, Michigan

Mayo Clinic - Rochester, Rochester, Minnesota

Saint Louis University Cancer Center, Saint Louis, Missouri

University Of Nebraska Medical Center, Omaha, Nebraska

Astera Cancer Care, East Brunswick, New Jersey

Astera Cancer Center, East Brunswick, New Jersey

Regional Cancer Care Associates-Freehold, Freehold, New Jersey

Hackensack University Medical John Theurer Cancer Center, Hackensack, New Jersey

Regional Cancer Care Associates LLC - Howell, Howell, New Jersey

Regional Cancer Care Associates LLC - Little Silver, Little Silver, New Jersey

New Mexico Cancer Care Alliance, Albuquerque, New Mexico

New York Oncology Hematology, P.C., Albany, New York

Northwell Health/Monter Cancer Center, Lake Success, New York

Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York

Columbia U - Herbert Irving Comprehensive Cancer Center, New York, New York

Memorial Sloan-Kettering Cancer Center, New York, New York

Hematology Oncology Associates of Rockland, P.C., Nyack, New York

Messino Cancer Center, Asheville, North Carolina

Levine Cancer Institute - Concord, Concord, North Carolina

FirstHealth of the Carolinas, Pinehurst, North Carolina

Gabrail Cancer Center Research, Canton, Ohio

Oncology Hematology Care (OHC), Inc. - Kenwood Office, Cincinnati, Ohio

Willamette Valley Cancer Institute and Research Center - Oncology, Eugene, Oregon

University of Pittsburgh Medical Center - Oncology, Pittsburgh, Pennsylvania

Western Pennsylvania Hospital Hematology & Cellular Therapy, Pittsburgh, Pennsylvania

Tennessee Oncology, PLLC, Chattanooga, Tennessee

University of Tennessee Medical Center - Cancer Institute, Knoxville, Tennessee

Sarah Cannon Research Institute, Nashville, Tennessee

Texas Oncology - Amarillo, Amarillo, Texas

Texas Oncology-Austin Midtown, Austin, Texas

Texas Oncology - Medical City Dallas Pediatric Hematology, Dallas, Texas

Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas

The University of Texas MD Anderson Cancer Center, Houston, Texas

Millennium Physicians - Oncology, Houston, Texas

Texas Oncology, Plano, Texas

Mays Cancer Center, San Antonio, Texas

UT Health East Texas HOPE Cancer Center - Tyler, Tyler, Texas

USO Texas Oncology - Tyler, Tyler, Texas

Texas Oncology- Weslaco, Weslaco, Texas

Utah Cancer Specialists/ IHO Corp, Salt Lake City, Utah

Huntsman Cancer Institute; The University of Utah, Salt Lake City, Utah

Peninsula Cancer Institute, Chesapeake, Virginia

Virginia Cancer Specialists, Gainesville, Virginia

Oncology and Hematology Associates of Southwest Virginia Inc., Roanoke, Virginia

MC Rockwood Cancer Bl Specialty Ctr - North, Spokane, Washington

Yakima Valley Memorial Hospital - North Star Lodge Cancer Center, Yakima, Washington

Royal Adelaide Hospital, Adelaide, South Australia

Flinders Medical Centre, Bedford Park, South Australia

Monash Health, Clayton, Victoria

Barwon Health, University Hospital Geelong, Geelong, Victoria

Hollywood Private Hospital, Nedlands, Western Australia

GenesisCare - St Andrew's, Adelaide, Not set

Peninsula Health - Frankston, Frankston, Not set

Gold Coast University Hosptial, Southport, Not set

CHU Dinant Godinne UCL Namur, Yvoir, Namur

Universitair Ziekenhuis Gent, Gent, Oost-Vlaanderen

UZ Leuven - Campus Gasthuisberg, Leuven, Vlaams Brabant

University Health Network Princess Margaret Hospital, Toronto, Ontario

Centre Hospitalier de l'Universite de Montreal (CHUM), Montréal, Quebec

Sir Mortimer B Davis/Jewish General Hospital, Montréal, Quebec

Fujian Medical University Union Hospital, Fuzhou, Fujian

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian

The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou

The Second Affiliated Hospital Zhejiang University School of Medicine, Zhejiang, Hangzhou

The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei

Henan Provincial People's Hospital, Zhengzhou, Henan

Henan Cancer Hospital, Zhengzhou, Henan

Hunan Cancer Hospital, Changsha, Hunan

The First Bethune Hospital of Jilin University, Changchun, Jinlin

The Affiliated Hospital of Qingdao University, Qingdao, Shandong

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai

Shanxi Bethune Hospital, Taiyuan, Shanxi

Peking University Third Hospital, Beijing, Not set

Tianjin Medical University Cancer Institute & Hospital, Tianjin, Not set

Centre Hospitalier Universitaire de Bordeaux-Hopital du Haut Leveque, Pessac Cedex, Aquitaine

CHRU Brest Hôp Morvan, Brest, Bretagne

Institut Bergonie, Bordeaux, Gironde

Centre Hosp Mulh Hop Emile Muller, Mulhouse, Haut-Rhin

Centre Henri Becquerel, Rouen, Haute-Normandie

CHU de Limoges Dupuytren, Limoges, Haute-Vienne

CHU de Grenoble - Hopital Albe, La Tronche, Isere

CHU de Nantes - Hematologie, Nantes, Loire-Atlantique

CHRU de Lille Hop Claude Huriez, Lille, Nord

Centre Hospitalier Le Mans, Le Mans, Sarthe

Centre Hospitalier Universitaire D'Angers - Hématologie Clinique, Angers, Not set

CHRU de Besançon- Hopital Jean Minjoz, Besancon, Not set

CHU Caen, Caen, Not set

CHU de Clermont-Ferrand, site Estaing, Clermont-Ferrand, Not set

Centre Hospitalier Docteur Schaffner, Lens, Not set

L'Hôpital Privé Confluent, Nantes, Not set

L'hôpital Privé du Concluent, Nantes, Not set

Hopital Saint Louis, Paris, Not set

Centre Hospitalier Universitaire de Poitiers, Poitiers, Not set

Centre Hospitalier - Hôpital de jour d'Hématologie, Périgueux, Not set

CHU de Nancy Brabois, Vandœuvre-lès-Nancy, Not set

Centre Hospitalier Bretagne Atlantique, Vannes, Not set

Institut Gustave Roussy, Villejuif, Not set

Hopital Henri Mondor - Hemopathies Lymphoides, Créteil, Île-de-France

Diakoneo Diak Schwaebisch Hall gGmbH, Schwäbisch Hall, Baden-Württemberg

Klinikum Der Universität München AöR, München, Bayern

Klinikum rechts der Isar der Technischen Universitat Muenche, München, Bayern

Universitätsmedizin Mainz, Mainz, Hessen

Universitaetsklinikum Bonn AöR, Bonn, Nordrhein-Westfalen

Kliniken Maria Hilf GmbH, Moenchengladbach, Nordrhein-Westfalen

Städt. Krankenhaus Kiel, Kiel, Schleswig-Holstein

Debreceni Egyetem Klinikai Központ, Debrecen, Hajdú-Bihar

Semmelweis Egyetem Általános Orvostudományi Kar, Budapest, Not set

Országos Onkológiai Intézet, Budapest, Not set

Del-pesti Centrumkorhaz Orszagos Hematologiai és Infektologiai Intezet, Budapest, Not set

AOU Federico II, Napoli, Campania

Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori IRCCS, Meldola, Forli-Cesena

ASST Spedali Civili di Brescia, Brescia, Not set

PO Garibaldi-Nesima, ARNAS Garibaldi, Catania, Not set

AOU Careggi, Firenze, Not set

Ospedale Vito Fazzi, ASL Lecce, Lecce, Not set

IEO - Istituto Europeo di Oncologia, IRCCS, Milano, Not set

Ospedale Maggiore Policlinico, Fondazione IRCCS Ca' Granda, Milano, Not set

Ospedale San Gerardo, ASST di Monza, Monza, Not set

Ospedale Civile S.Spirito, PO di Pescara, AUSL Pescara, Pescara, Not set

Ospedale Infermi di Rimini, AUSL Rimini, Distretto di Rimini, Presidio di Rimini, Santarcangelo di Romagna e Novafeltria, Rimini, Not set

Catholic University Of Sacred Heart, Roma, Not set

PU Campus Bio-Medico di Roma, Roma, Not set

Regina Elena, Istituto Nazionale dei Tumori , IFO, IRCCS, Roma, Not set

Azienda Ospedaliera Santa Maria di Terni, Terni, Not set

Azienda Ospedaliera Ordine Mauriziano di Torino, Ospedale Umberto I di Torino, Torino, Not set

Azienda Sanitaria Universitaria Giuliano Isontina (ASU GI), Ospedale Maggiore, Trieste, Not set

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Seoul Teugbyeolsi [Seoul-T'ukp]

Severance Hospital, Yonsei University Health System, Seoul, Seoul Teugbyeolsi [Seoul-T'ukp

Samsung Medical Center, Seoul, Seoul Teugbyeolsi [Seoul-T'ukp

Seoul National University Hospital, Seoul, Seoul Teugbyeolsi

Pusan National University Hospital, Busan, Not set

Gachon University Gil Medical Center, Incheon, Not set

Ajou University Hospital, Suwon, Not set

Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Warszawa, Mazowieckie

Centrum Medyczne Pratia Poznan, Skorzewo, Wielkopolskie

Pratia Onkologia Katowice, Katowice, Not set

Pratia MCM Krakow, Kraków, Not set

Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka w Slupsku Sp. z o.o., Słupsk, Not set

MICS Centrum Medyczne Torun, Torun, Not set

MTZ Clinical Research powered by Pratia, Warszawa, Not set

Uniwersytecki Szpital Kliniczny im. J. Mikulicza-Radeckiego we Wroclawiu, Wroclaw, Not set

Hospital Universitari Vall d'Hebrón, Barcelona, Cataluny

Hospital Costa del Sol, Marbella, Málaga

Hospital Del Mar, Barcelona, Not set

Hospital Univ. Infanta Leonor, Madrid, Not set

Hospital Universitario La Paz, Madrid, Not set

Hospital Universitario de Salamanca, Salamanca, Not set

Hospital Universitario Nuestra Señora de Valme, Sevilla, Not set

Buddihist Tzu Chi Medical Foundation- Hualien Tzu Chi Hospital, Hualien City, Not set

Chang Gung Medical Foundation - Kaohsiung Chang Gung Memorial Hospital - Hemato-Oncology, Kaohsiung, Not set

Taichung Veterans General Hospital, Taichung, Not set

National Cheng Kung University Hospital, Tainan, Not set

National Taiwan University Hospital, Taipei, Not set

Ankara University Medical Faculty - Hematology, Ankara, Not set

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research, Ankara, Not set

Gazi University Medical Faculty, Ankara, Not set

Ondokuz Mayis University Medical Faculty - Hematology, Samsun, Not set

Western General Hospital - Haematology, Edinburgh, Edinburgh, City Of

Imperial College Healthcare NHS Trust - Hammersmith Hospital, London, London City

St Bartholomew's Hospital Barts Health NHS Trust, London, London, City Of

Royal Cornwall Hospitals NHS Trust - Royal Cornwall Hospital, Cornwell, Not set

Beatson West of Scotland Cancer Centre, Glasgow, Not set

Northwick Park Hospital Middlesex, United Kindgom, HA1 3UJ, Middlesex, Not set

Conditions: Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma

Learn More ›

A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting

NCT06794268

Recruiting

The purpose of this study is to characterise the long-term safety of lisocabtagene maraleucel, focusing on patients treated in the approved follicular lymphoma (FL) indication, and will be part of post-marketing liso-cel pharmacovigilance activities

Gender:

ALL

Ages:

18 years and above

Trial Updated:

02/21/2025

Locations: CIBMTR, Milwaukee, Wisconsin

Conditions: Follicular Lymphoma

Learn More ›

1 - 12 of 58